Instructions for use Flekosteel

How to use gel Flekosteel Instruction in Poland

Gel for joints and waist

Method of administration and dosage

For adults and children over 12 years of age, the drug is administered in a dose of 2 g (approximately 4 cm with a completely open mouth) in a thin layer on the inflamed area 2-3 times a day. tube) and lightly rubbed. Single dose of sweat - 2 g The maximum daily dose of the drug should not exceed 6 g. Use in minimum effective doses for a minimum short course. Use Flekosteel only as directed. in the doses indicated in the application and instructions.

Indicators	Contraindications
post-traumatic inflammation of soft tissues, such as sprains, strains, bruises, injuries; - rheumatic diseases and swelling of soft tissues (tendovaginitis, bursitis, periarticular tissue damage, wrist syndrome); - joint pains (finger joints), knees, etc. ) with osteoarthritis; - back pain in inflammatory and degenerative diseases of the spine (osteoarthritis, sciatica, lumbago, sciatica). The drug is used for symptomatic therapy, reduces pain and inflammation during use. affects the development of the disease.	- hypersensitivity to diclofenac or other components of the drug; - complete or incomplete combination of bronchial asthma, recurrent polyposis of the nasal colonic sinuses, intolerance to salicylates or other NSAIDs (including history); - pregnancy (III trimester); - lactation period; - age of children (up to 12 years); - violation of the integrity of the skin at the intended application.

Indicators

Contraindications

post-traumatic inflammation of soft tissues, such as sprains, strains, bruises, injuries; - rheumatic diseases and swelling of soft tissues (tendovaginitis, bursitis, periarticular tissue damage, wrist syndrome); - joint pains (finger joints), knees, etc. ) with osteoarthritis; - back pain in inflammatory and degenerative diseases of the spine (osteoarthritis, sciatica, lumbago, sciatica). The drug is used for symptomatic therapy, reduces pain and inflammation during use. affects the development of the disease.

- hypersensitivity to diclofenac or other components of the drug; - complete or incomplete combination of bronchial asthma, recurrent polyposis of the nasal colonic sinuses, intolerance to salicylates or other NSAIDs (including history); - pregnancy (III trimester); - lactation period; - age of children (up to 12 years); - violation of the integrity of the skin at the intended application.